BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19940646)

  • 1. Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2009; 33(6):834-7. PubMed ID: 19940646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2010; 34(2):173-6. PubMed ID: 20351498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones.
    Kilickesmez O; Bayramoglu S; Inci E; Cimilli T; Kayhan A
    Acta Radiol; 2009 Apr; 50(3):340-7. PubMed ID: 19235579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion.
    Takeuchi M; Matsuzaki K; Nishitani H
    Acta Radiol; 2009 Oct; 50(8):947-53. PubMed ID: 19724949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.
    Liu Y; Bai R; Sun H; Liu H; Wang D
    J Comput Assist Tomogr; 2009; 33(6):858-62. PubMed ID: 19940650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microstructural changes in uterine leiomyomas and myometrium: a diffusion-weighted magnetic resonance imaging study.
    Erdem G; Celik O; Karakas HM; Hascalik S; Firat AK
    Gynecol Obstet Invest; 2009; 67(4):217-22. PubMed ID: 19169036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation between completely hyalinized uterine leiomyomas and ordinary leiomyomas: three-phase dynamic magnetic resonance imaging (MRI) vs. diffusion-weighted MRI with very small b-factors.
    Shimada K; Ohashi I; Kasahara I; Watanabe H; Ohta S; Miyasaka N; Itoh E; Shibuya H
    J Magn Reson Imaging; 2004 Jul; 20(1):97-104. PubMed ID: 15221814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of diffusion-weighted MR imaging in differentiation of uterine adenomyosis and leiomyoma.
    Yang Q; Zhang LH; Su J; Liu J
    Eur J Radiol; 2011 Aug; 79(2):e47-51. PubMed ID: 21458180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions.
    Fujii S; Kakite S; Nishihara K; Kanasaki Y; Harada T; Kigawa J; Kaminou T; Ogawa T
    J Magn Reson Imaging; 2008 Nov; 28(5):1149-56. PubMed ID: 18972356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted imaging of primary brain lymphomas: effect of ADC value and signal intensity of T2-weighted imaging.
    Akter M; Hirai T; Makino K; Kitajima M; Murakami R; Fukuoka H; Sasao A; Kuratsu J; Yamashita Y
    Comput Med Imaging Graph; 2008 Oct; 32(7):539-43. PubMed ID: 18617368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
    Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
    Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of diffusion-weighted imaging for the differential diagnosis between chronic expanding hematomas and malignant soft tissue tumors.
    Oka K; Yakushiji T; Sato H; Yorimitsu S; Hayashida Y; Yamashita Y; Mizuta H
    J Magn Reson Imaging; 2008 Nov; 28(5):1195-200. PubMed ID: 18972359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging.
    Koşucu P; Tekinbaş C; Erol M; Sari A; Kavgaci H; Oztuna F; Ersöz S
    J Magn Reson Imaging; 2009 Aug; 30(2):292-7. PubMed ID: 19629990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
    Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
    Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MR imaging of uterine endometrial cancer.
    Tamai K; Koyama T; Saga T; Umeoka S; Mikami Y; Fujii S; Togashi K
    J Magn Reson Imaging; 2007 Sep; 26(3):682-7. PubMed ID: 17729360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density.
    Tasaki A; Asatani MO; Umezu H; Kashima K; Enomoto T; Yoshimura N; Aoyama H
    Abdom Imaging; 2015 Aug; 40(6):1742-52. PubMed ID: 25526683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of apparent diffusion coefficients to differentiate benign from malignant vertebral bone marrow lesions.
    Balliu E; Vilanova JC; Peláez I; Puig J; Remollo S; Barceló C; Barceló J; Pedraza S
    Eur J Radiol; 2009 Mar; 69(3):560-6. PubMed ID: 18276098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
    Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
    J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
    Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.
    Namimoto T; Yamashita Y; Awai K; Nakaura T; Yanaga Y; Hirai T; Saito T; Katabuchi H
    Eur Radiol; 2009 Nov; 19(11):2756-64. PubMed ID: 19504102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.